{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "20456842", "DateCompleted": {"Year": "2012", "Month": "03", "Day": "06"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1672-1977", "JournalIssue": {"Volume": "8", "Issue": "5", "PubDate": {"Year": "2010", "Month": "May"}}, "Title": "Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine", "ISOAbbreviation": "Zhong Xi Yi Jie He Xue Bao"}, "ArticleTitle": "Preclinical safety evaluation of the aqueous acetone extract of Chinese herbal formula Modified Huo Luo Xiao Ling Dan.", "Pagination": {"StartPage": "438", "EndPage": "447", "MedlinePgn": "438-47"}, "Abstract": {"AbstractText": ["To investigate the safety of oral administration of Modified Huo Luo Xiao Ling Dan (HLXLD), a compound traditional Chinese herbal medicine.", "The toxicological information of HLXLD and its individual constituent herbs was searched in cintcm or TCMlars (www.cintcm.com), PubMed (MEDLINE), Chinese Herbal Medicine (1999) and WHO Monographs on Selected Medicinal Plants (Vol. I- III). Single-dose acute toxicity was assessed by using the highest possible dosage. Motor function test was used to determine whether the herbal formula might cause motor impairment. Nine-day HLXLD repeat-dose sub-chronic toxicity/adverse effects, and 42-day chronic toxicity/adverse effects in rats were also assessed.", "The literature searches showed that HLXLD and its eleven ingredient herbs had no side/adverse effects listed in the traditional Chinese medicine literature. Under the dosages proposed in the formula, the HLXLD formula had no side/adverse effects according to MEDLINE, Chinese Herbal Medicine and WHO Monographs on Selected Medicinal Plants. The studies in rats showed: (1) in single-dose acute toxicity assessment, the maximal feasible single oral dose, 9.20 g/kg HLXLD, showed no significant effect on clinical signs, or body weight and mortality over a 14-day period in rats; (2) during motor function test, nine-day repeat-dose of daily HLXLD treatment at 4.60 g/kg did not cause motor impairment; (3) in nine-day HLXLD repeat-dose sub-chronic toxicity/adverse effects assessment, there were no noticeable abnormal behavioral changes or obvious adverse reactions and signs in complete Freund's adjuvant inflamed rats (highest observed dosage: 4.60 g/kg), and no noticeable adverse effects were observed during, or 14 days after nine-day treatment at 4.60 g/kg in non-inflamed rats; (4) during 42-day chronic toxicity/adverse effects assessments, no noticeable abnormal behavioral changes, no obvious adverse reactions and signs were observed in normal rats administered with HLXLD at a dose of 2.30 g/kg and the values of serum biochemistry and histopathology were in normal range.", "Both existing information and animal data support that Modified HLXLD is a safe herbal product for clinical application."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Integrative Medicine, University of Maryland, Baltimore, MD 21201, USA. ArthurFan@ChineseMedicineDoctor.US"}], "Identifier": [], "LastName": "Fan", "ForeName": "Arthur Yin", "Initials": "AY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lao", "ForeName": "Lixing", "Initials": "L"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "Rui-xin", "Initials": "RX"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhou", "ForeName": "An-nan", "Initials": "AN"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Berman", "ForeName": "Brian M", "Initials": "BM"}], "GrantList": [{"GrantID": "P50 AT000084", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}, {"GrantID": "P50-AT00084", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Zhong Xi Yi Jie He Xue Bao", "NlmUniqueID": "101199657", "ISSNLinking": "1672-1977"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "huo luo xiao ling dan"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Drug Evaluation, Preclinical"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": ["administration & dosage", "adverse effects"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": [], "DescriptorName": "Toxicity Tests, Chronic"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bensky D, Gamble A. Chinese herbal medicine: materia medica[M] Revised ed Eastland Press; Seattle: 1993. pp. 82\u201383."}, {"Citation": "World Health Organization  Medicinal plants \u2014 guidelines to promote patient safety and plant conservation for a US $ 60 billion industry. Note for the Press. 2004 Feb 10;3 [2010-03-18].  http://www.who.int/mediacentre/news/notes/2004/np3/en/"}, {"Citation": "Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002 [J] Adv Data. 2004;(343):1\u201319.", "ArticleIdList": ["15188733"]}, {"Citation": "Sun SM. Valuable prescriptions[M] China Press of Traditional Chinese Medicine; Beijing: 1998. Chinese."}, {"Citation": "Wu Q. Golden mirror of medicine[M] People's Medical Publishing House; Beijing: 2004. Chinese."}, {"Citation": "Peng HR. Grand dictionary of Chinese medicinal formulas[M] People's Medical Publishing House; Beijing: 1998. Chinese."}, {"Citation": "Shennong's pharmacopoeia[M] Academy Press; Beijing: 2002. Chinese."}, {"Citation": "Li SZ. Compendium of materia medica[M] People's Medical Publishing House; Beijing: 2005. Chinese."}, {"Citation": "Editorial Committee of Chinese Herbal Medicine. State Administration of Traditional Chinese Medicine . Chinese herbal medicine[M] Shanghai Scientific and Technical Publishers; Shanghai: 1999."}, {"Citation": "Bensky D, Barolet R. Chinese herbal medicine: formulas and strategies[M] Eastland Press; Seattle: 1990. pp. 329\u2013330."}, {"Citation": "Sharma H. Phytochemical synergism: beyond the active ingredient model[J] Altern Ther Clin Pract. 1997;4:91\u201396."}, {"Citation": "Zhu YP. Chinese materia medica: chemistry, pharmacology and applications[M] Harwood Academic Publishers; Amsterdam: 1998. pp. 27\u201332."}, {"Citation": "China Pharmacopoeia Commission . Pharmacopoeia of the People's Republic of China[M] 2000 ed. Chemical Industry Press; Beijing: 2000. Chinese."}, {"Citation": "Zhang XC. Records of tradtional Chinese and Western medicine in combination[M] People's Medical Publishing House; Beijing: 2006. Chinese."}, {"Citation": "Yao DS. Modified Huoluo Xiaoling Dan in treatment of arthritis: a report of 123 cases[J] Hubei Zhong Yi Za Zhi. 1986;(5):21\u201322. Chinese."}, {"Citation": "Qu YN, Tang BW. The experience in clinical application of Huoluo Xiaoling Dan[J] Jilin Zhong Yi Yao. 1990;(3):28. Chinese."}, {"Citation": "Sun JH, Tao ZG. Huoluo Xiaoling Dan combined with Simiao Yong'an Tang in treatment of thromboangiitis: a report of 17 cases[J] Shandong Zhong Yi Za Zhi. 1991;10(5):24. Chinese."}, {"Citation": "Tang QL. The application of Huoluo Xiaoling Dan in surgery department[J] Jiangsu Zhong Yi. 1992;(2):32\u201333. Chinese."}, {"Citation": "Wang MY, Yi FS. Modified Huoluo Xiaoling Dan in treating atrophic gastritis: a report of 95 cases[J] Sichuan Zhong Yi. 1994;(1):25\u201326. Chinese."}, {"Citation": "Wu YN, Hua L, Zhang FY, Jin Y, Zhang XH. Conservative therapy of combining laparoscopy and Chinese medicine for ectopic pregnancy[J] Zhongguo Zhong Xi Yi Jie He Za Zhi. 1994;14(10):583\u2013585. Chinese with abstract in English.", "ArticleIdList": ["7719087"]}, {"Citation": "Wang TC, Du LH, Wang B, Zhang G. The experimental study of protective effect of Huoluoshugan Capsule on acute hepatic injury[J] Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi. 2002;10(1):27\u201328. Chinese with abstract in English."}, {"Citation": "Wang YC, Ji SY, Wang R. The clinical applications of Huoluo Xiaoling Dan[J] Zhong Yi Yao Xue Bao. 2002;30(2):53. Chinese."}, {"Citation": "Fan AY, Lao L, Zhang RX, Wang LB, Lee DY, Ma ZZ, Zhang WY, Berman B. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on rats with persistent inflammation[J] J Altern Complement Med. 2005;11(2):323\u2013331.", "ArticleIdList": ["15865500"]}, {"Citation": "Lao L, Fan AY, Zhang RX, Zhou A, Ma ZZ, Lee DY, Ren K, Berman B. Anti-hyperalgesic and anti-inflammatory effects of the modified Chinese herbal formula Huo Luo Xiao Ling Dan (HLXL) in rats[J] Am J Chin Med. 2006;34(5):833\u2013844.", "ArticleIdList": ["17080548"]}, {"Citation": "Fan AY, Lao L, Zhang RX, Zhou AN, Wang LB, Moudgil KD, Lee DY, Ma ZZ, Zhang WY, Berman BM. Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on adjuvant-induced arthritis in lewis rats[J] J Ethnopharmacol. 2005;101(1\u20133):104\u2013109.", "ArticleIdList": ["15970410"]}, {"Citation": "Zhang RX, Fan AY, Zhou AN, Moudgil KD, Ma ZZ, Lee DY, Fong HH, Berman BM, Lao L. Extract of the Chinese herbal formula Huo Luo Xiao Ling Dan inhibited adjuvant arthritis in rats[J] J Ethnopharmacol. 2009;121(3):366\u2013371.", "ArticleIdList": ["PMC2818782", "19100323"]}, {"Citation": "World Health Organization . WHO monographs on selected medicinal plants (Vol. I, II, III)[M] WHO Press; Geneva: 1999."}, {"Citation": "Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals[J] Pain. 1983;16(2):109\u2013110.", "ArticleIdList": ["6877845"]}, {"Citation": "Food and Drug Administration Center for Drug Evaluation and Research (CDER)  Guidance for industry: botanical drug products. 2004 [2010-03-18].  http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/ucm070491.pdf."}, {"Citation": "Food and Drug Administration Center for Drug Evaluation and Research (CDER)  Guidance for industry: single dose acute toxicity testing for pharmaceutics. 1996 [2010-03-18].  http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079270.pdf."}, {"Citation": "State Administration of Traditional Chinese Medicine . State Administration of Traditional Chinese Medicine. Guidelines for developing new Chinese herbal medicine. 1999. Testing guidelines for safety evaluation of new drug. Chinese."}, {"Citation": "Lao L, Zhang G, Wei F, Berman BM, Ren K. Electro-acupuncture attenuates behavioral hyperalgesia and selectively reduces spinal Fos protein expression in rats with persistent inflammation[J] Pain. 2001;2(2):111\u2013117.", "ArticleIdList": ["14622832"]}, {"Citation": "Shen YJ, Sun RY. The experimental methods of toxicity and safety evaluation on Chinese herbal medicine. In: Chen Q, editor. Technology of research on pharmacology of traditional Chinese medicine[M] People's Medical Publishing House; Beijing: 2000. pp. 117\u2013118. Chinese."}, {"Citation": "Cao H, Wang ST, Wu LY, Wang XT, Jiang AP. Pharmacological study on Tianxiong (tuber of Aconitum carmichaeli Debx.), a Chinese drug for reinforcing the kidney yang retail in Hong Kong market[J] Zhongguo Zhong Yao Za Zhi. 2001;26(6):369\u2013372. Chinese with abstact in English.", "ArticleIdList": ["12528501"]}, {"Citation": "Gad SC. Drug safety evaluation[M] Wiley-Interscience, John Wiley and Sons, Inc; New York: 2002. pp. 131\u2013504."}, {"Citation": "Shin SS, Jin M, Jung HJ, Kim B, Jeon H, Choi JJ, Kim JM, Cho BW, Chung SH, Lee YW, Song YW, Kim S. Suppressive effect of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice[J] Rheumatology (Oxford) 2003;42(5):665\u2013672.", "ArticleIdList": ["12709543"]}, {"Citation": "Wei F, Zou S, Young A, Dubner R, Ren K. Effects of four herbal extracts on adjuvant-induced inflammation and hyperalgesia in rats[J] J Altern Complement Med. 1999;5(5):429\u2013436.", "ArticleIdList": ["10537242"]}, {"Citation": "Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L. Antipsychotics in bipolar disorders[J] Encephale. 2004;30(5):417\u2013424.", "ArticleIdList": ["15627046"]}, {"Citation": "Paulson GW. Historical comments on tardive dyskinesia: a neurologist's perspective[J] J Clin Psychiatry. 2005;66(2):260\u2013264.", "ArticleIdList": ["15705014"]}, {"Citation": "Bausell RB, Li YF. Power analysis for experimental research: a practical guide for the biological, medical, and social sciences[M] Press Syndicate of Cambridge University; Cambridge: 2002."}, {"Citation": "Sigurj\u00f3nsd\u00f3ttir HA, Franzson L, Manhem K, Ragnarsson J, Sigurdsson G, Wallerstedt S. Liquorice-induced rise in blood pressure: a linear dose-response relationship[J] J Hum Hypertens. 2001;15(8):549\u2013552.", "ArticleIdList": ["11494093"]}, {"Citation": "Hann SK, Park YK, Im S, Byun SW. Angelica-induced phytophotodermatitis[J] Photodermatol Photoimmunol Photomed. 1991;8(2):84\u201385.", "ArticleIdList": ["1756118"]}, {"Citation": "Heck AM, DeWitt BA, Lukes AL. Potential interactions between alternative therapies and warfarin[J] Am J Health Syst Pharm. 2000;57(13):1221\u20131227.", "ArticleIdList": ["10902065"]}, {"Citation": "Loeb WF, Quimby FW. The clinical chemistry of laboratory animals[M] 2nd ed Taylor & Francis; Philadelphia: 1999. pp. 647\u2013692."}]}], "History": [{"Year": "2010", "Month": "5", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2010", "Month": "5", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2012", "Month": "3", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2013", "Month": "8", "Day": "10"}], "PublicationStatus": "ppublish", "ArticleIdList": ["20456842", "NIHMS496306", "PMC3739922", "10.3736/jcim20100507", "jcim20100507"]}}], "PubmedBookArticle": []}